ePharmaceuticals launches drug safety newsletter

May 9, 2006 — MARBLEHEAD, Mass. — MEDICAL INDUSTRY E-MAIL NEWS SERVICE(TM) — ePharmaceuticals, a division of healthcare regulatory publisher HCPro, has launched Briefings on Drug Safety. The monthly electronic newsletter provides information and guidance to help pharmaceutical professionals make smart drug safety, risk management and marketing decisions.

With thousands of Vioxx-related product liability lawsuits, tighter oversight by the FDA’s new Office of Drug Safety, FDA-mandated risk management plans and risk communication, and intense Congressional and media scrutiny, drug safety is in the spotlight more than ever before. These factors have created an environment in which pre- and post-approval drug safety, risk management and risk communications, can make or break a drug.

“The drug safety stakes have never been higher, and that’s why drug safety, regulatory, legal, and marketing professionals in the pharmaceutical and biotech industries need this newsletter,” said David Beardsley, Publisher of Briefings on Drug Safety.

Briefings on Drug Safety is designed to help readers effectively initiate post-approval safety studies, prepare for rigorous FDA oversight of drug safety, comply with adverse event reporting requirements, and design risk management and risk communications plans.

This new launch further expands ePharmaceuticals’ line of informational and training products on regulatory compliance in the life sciences industries. These products and services include newsletters, audio conferences, webcasts, training handbooks, e-learning and onsite workshops. They cover drug safety/risk management, Part D compliance, formulary and reimbursement issues under Medicare Parts B & D, and marketing innovation.


For more information, including a complimentary copy of Briefings on Part D Compliance, please visit:


ePharmaceuticals, a division of healthcare regulatory publisher HCPro, Inc., provides business intelligence, compliance training, market research reports and custom publishing services to the pharmaceutical industry.

Publications include ePharm5, a daily business and marketing innovation newsletter, Medicare & Reimbursement Advisor Weekly, Briefings on Part D Compliance, Briefings on Drug Safety, and Pharmaceutical Compliance Alert.

Our compliance training resources include handbooks, audioconferences, live workshops, and online learning courses


David Beardsley
Publisher, Briefings on Drug Safety
ePharmaceuticals, Inc.
200 Hoods Ln PO Box 1168
Marblehead MA USA 01945
877-437-4276 phone
781-639-1872 ext 3218 phone
[email protected]


Easily post a comment below using your Linkedin, Twitter, Google or Facebook account. Comments won't automatically be posted to your social media accounts unless you select to share.